Innovative Treatment for Incurable Disease
HuRicell-Hepa™ is a cell therapy product using cord-derived mesenchymal stem cells for liver disease treatment
Status of Current Research
Hepatitis, liver cirrhosis, fatty liver, and liver cancer are the 3rd leading causes of death in the 40s and 50s.
Liver transplantation is the most efficient treatment, but the burden of medical expenses and the lack of donors have shifted the public interest to cell therapy.
HuRicell-Hepa™ is an allogeneic cell therapy product using the umbilical cord with the possibility of mass production.
Patients in Korea (Liver disease)